Skip to main content

Maple Capital Management, Inc.

SEC CIK
0001313893
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Maple Capital Management, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
166,641
Value
$15.1M
% of portfolio
0.9%
Quarters held
22
Since Q1 2021
Holdings of ABT by Maple Capital Management, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026166,641$15.1M0.9%−2,011−1.2%ReducedHolders
Q1 2026168,652$17.3M1.2%−2,966−1.7%ReducedHolders
Q4 2025171,618$21.5M1.4%−871−0.5%ReducedHolders
Q3 2025172,489$23.1M1.5%+292+0.2%AddedHolders
Q2 2025172,197$23.4M1.6%+2,240+1.3%AddedHolders
Q1 2025169,957$22.5M1.7%+584+0.3%AddedHolders
Q4 2024169,373$19.2M1.4%−363−0.2%ReducedHolders
Q3 2024169,736$19.4M1.5%+447+0.3%AddedHolders
Q2 2024169,289$17.6M1.4%+1,640+1.0%AddedHolders
Q1 2024167,649$19.1M1.7%+1,037+0.6%AddedHolders
Q4 2023166,612$18.3M1.8%+1,343+0.8%AddedHolders
Q3 2023165,269$16.0M1.8%−814−0.5%ReducedHolders
Q2 2023166,083$18.1M2.0%−1,353−0.8%ReducedHolders
Q1 2023167,436$17.0M2.1%−1,228−0.7%ReducedHolders
Q4 2022168,664$18.5M2.5%−1,604−0.9%ReducedHolders
Q3 2022170,268$17.4M2.2%+690.0%AddedHolders
Q2 2022170,199$18.5M2.4%+399+0.2%AddedHolders
Q1 2022169,800$20.1M2.4%−4,118−2.4%ReducedHolders
Q4 2021173,918$24.5M2.7%−6,622−3.7%ReducedHolders
Q3 2021180,540$21.3M2.7%−1,805−1.0%ReducedHolders
Q2 2021182,345$22.4M2.7%+1,994+1.1%AddedHolders
Q1 2021180,351$21.6M3.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.